Squarepoint Ops LLC Capricor Therapeutics, Inc. Transaction History

Squarepoint Ops LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 27, 2025	SELL	$6.34 - $14.23 $866,044 - $1.94 Million	-136,600 Reduced 79.78%	34,613 $343,000
Q2 2025 Aug 14, 2025	SELL	$6.34 - $14.23 $866,044 - $1.94 Million	-136,600 Reduced 79.78%	34,613 $343,000
Q1 2025 Aug 27, 2025	BUY	$9.49 - $16.11 $1.3 Million - $2.2 Million	136,600 Added 394.65%	171,213 $1.62 Million
Q1 2025 May 15, 2025	BUY	$9.49 - $16.11 $1.37 Million - $2.32 Million	144,226 Added 534.43%	171,213 $1.62 Million
Q4 2024 Feb 14, 2025	BUY	$12.9 - $21.99 $348,132 - $593,444	26,987 New	26,987 $373,000

Q2 2024 Aug 14, 2024	BUY	$4.63 - $7.09 $105,077 - $160,907	22,695 New	22,695 $108,000

141

13.3M

2.76M

Ticker CAPR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 24,346,200
Market Cap $137M
Description
Capricor Therapeutics, Inc., a clinical-stage biotechnology company, focuses on the development of transformative cell and exosome-based therapeutics for the treatment and prevention of spectrum of diseases and disorders. Its lead candidate, CAP-1002, an allogeneic cardiac-derived cell therapy, which has completed phase III clinical trial for th...

Get notified when there are updates to the investment portfolio of Squarepoint Ops LLC, based on Form 13F filings with the SEC.

Stay updated on Squarepoint Ops LLC with notifications on news.